ER
Elena Ridloff

Elena Ridloff insider trades: Kymera Therapeutics (KYMR) stock buys and sales

Kymera Therapeutics Last trade May 11, 2026 33 Form 4 filings
$1.3M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2019
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Elena reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 11, 2026KYMR↓ Sell$261K
Apr 1, 2026KYMR↓ Sell$1.0M
Sep 2, 2025SION↓ Sell$240K
Aug 28, 2025SION↓ Sell$602K
Aug 20, 2025SION↓ Sell$1.1M
Jun 11, 2025KYMR↓ Sell$225K
Jun 3, 2025KYMR↓ Sell$553K
Apr 30, 2021ACAD↓ Sell$21K
Feb 4, 2021ACAD↓ Sell$104K
Jan 6, 2021ACAD↓ Sell$54K
Oct 14, 2020KRON↑ Buy$50K
Apr 30, 2020ACAD↓ Sell$559K
Dec 9, 2019ACAD↓ Sell$1.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other KYMR insiders

Open-market trades in the last 12 months

About Elena Ridloff's insider trades

Elena Ridloff is an insider at Kymera Therapeutics (KYMR). Since Dec 9, 2019, Elena has reported 1 open-market purchase worth $50K and 12 sales worth $6.6M on SEC Form 4. In the last 12 months: 2 sales ($1.3M).

Their filings also include grants and awards (20 filings), option exercises (8 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.